At 38 weeks gestation, a fetus has asymmetric growth restriction (abdominal circumference ~2nd percentile, estimated fetal weight ~20th percentile), a normal amniotic fluid index (AFI) of 8.23, and a ductus arteriosus Doppler systolic/diastolic (S/D) ratio of 2.11; what is the recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management at 38 Weeks with Asymmetric FGR, Normal AFI, and Ductus Arteriosus S/D 2.11

Proceed to delivery at 37-38 weeks gestation based on the presence of asymmetric growth restriction with abdominal circumference at the 2nd percentile, regardless of the ductus arteriosus Doppler findings. 1, 2

Critical Assessment Required

The ductus arteriosus Doppler S/D ratio of 2.11 should not guide management decisions. The Society for Maternal-Fetal Medicine explicitly recommends against using ductus venosus, middle cerebral artery, or uterine artery Doppler for routine clinical management of fetal growth restriction—only umbilical artery Doppler has Level I evidence for guiding delivery timing. 2, 3

Immediate Actions Needed

  • Obtain umbilical artery Doppler immediately to determine the appropriate delivery timing, as this is the only vessel with Level I evidence showing a 29% reduction in perinatal mortality (RR 0.71,95% CI 0.52-0.98) in FGR management. 2

  • Perform cardiotocography (NST or biophysical profile) today to assess immediate fetal well-being, as weekly testing is recommended for FGR without absent/reversed end-diastolic velocity. 1, 2

Delivery Timing Algorithm Based on Umbilical Artery Doppler

The timing of delivery depends entirely on umbilical artery Doppler findings:

If Umbilical Artery Doppler Shows Normal Flow

  • Deliver at 38-39 weeks when estimated fetal weight is between 3rd-10th percentile with normal Doppler. 1, 2
  • Since the patient is already at 38 weeks, proceed with delivery planning now. 2

If Umbilical Artery Doppler Shows Decreased Diastolic Flow

  • Deliver at 37 weeks for decreased diastolic flow (elevated resistance >95th percentile but not absent). 1, 2
  • Since the patient is already beyond 37 weeks, deliver immediately. 2, 3

If Umbilical Artery Doppler Shows Absent End-Diastolic Velocity (AEDV)

  • Deliver urgently, preferably by cesarean section, as the recommended delivery window is 33-34 weeks and the fetus is now at 38 weeks—far beyond the safe window. 2, 3
  • At term with AEDV, there is no benefit to attempting vaginal delivery. 3

If Umbilical Artery Doppler Shows Reversed End-Diastolic Velocity (REDV)

  • Emergency cesarean delivery is required immediately, as the recommended delivery window is 30-32 weeks and this represents critical placental dysfunction. 2, 3
  • Do not attempt labor induction or allow spontaneous labor, as the fetus cannot tolerate the stress of contractions. 3

Additional Diagnostic Considerations

The severe asymmetry (abdominal circumference at 2nd percentile while estimated fetal weight is at 20th percentile) strongly suggests placental insufficiency rather than constitutional smallness. 1, 4

  • The abdominal circumference <10th percentile alone meets criteria for FGR diagnosis according to the 2020 Society for Maternal-Fetal Medicine guidelines. 2, 4

  • Severe FGR with estimated fetal weight <3rd percentile warrants delivery at 37 weeks regardless of Doppler findings. 1, 2

Mode of Delivery Planning

  • Cesarean delivery should be strongly considered if umbilical artery Doppler shows absent or reversed end-diastolic velocity, as 75-95% of such pregnancies require emergency cesarean for intrapartum fetal heart rate abnormalities. 2, 3

  • Continuous electronic fetal monitoring during labor is mandatory if vaginal delivery is attempted, as FGR fetuses are at high risk for intrapartum compromise even with normal antepartum testing. 2

Common Pitfalls to Avoid

  • Do not delay delivery based on the ductus arteriosus Doppler value—this vessel lacks evidence for guiding clinical management. 2, 3

  • Do not rely solely on normal AFI (8.23) or reassuring cardiotocography to defer delivery, as normal fetal heart rate testing does not exclude progression of growth restriction. 2

  • Do not use the normal estimated fetal weight (20th percentile) to dismiss the severity—the severe asymmetry with abdominal circumference at 2nd percentile indicates placental insufficiency requiring delivery. 1, 4

  • Do not discharge without obtaining umbilical artery Doppler—this is the only evidence-based surveillance tool that should guide delivery timing. 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Fetal Growth Restriction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Timing of Delivery for Fetal Growth Restriction (FGR) with Abnormal Dopplers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Impact of adding abdominal circumference to the definition of fetal growth restriction.

American journal of obstetrics & gynecology MFM, 2021

Related Questions

What are the pros and cons of opting for a cesarean section (C-section) in a large for gestational age (LGA) pregnancy, where the abdominal circumference is larger than the head circumference, and there are concerns about potential difficulties with vaginal delivery, such as the need for vacuum extraction or forceps delivery, in a primiparous (primip) mother?
What are the recommendations for a pregnant patient at 6 weeks 5 days gestation with a crown-rump length (CRL) of 0.48cm, fetal heart rate (FHR) of 111 beats per minute, yolk sac (YS) measuring 0.50cm, and gestational sac measuring 0.98cm, indicating a potential discrepancy in gestational age and fetal size?
What is the most effective method for calculating fetal growth?
What are the diagnostic criteria for Fetal Growth Restriction (FGR) using Ultrasound (USG) Doppler?
Is my fetus's growth restriction (asymmetric, abdominal circumference ~2nd percentile, estimated weight ~20th percentile at 38 weeks) likely due to genetics given a petite relative and another relative who delivered a <7‑lb infant at 42 weeks, or is it more likely caused by placental insufficiency?
In the emergency department, how should I manage a reproductive‑age woman who presents within 120 hours of unprotected intercourse with a negative pregnancy test (emergency contraception options) and a patient presenting with acute uterine fibroid complications such as severe menorrhagia, anemia, or acute pelvic pain?
What is the recommended management for a pregnant patient with gestational diabetes mellitus and intra‑uterine growth restriction who has developed anhydramnios?
What are the causes of enthesophytes?
In adults, when is fish oil (eicosapentaenoic acid + docosahexaenoic acid) supplementation indicated, what doses are recommended for triglyceride lowering versus primary or secondary cardiovascular prevention, and what safety considerations apply?
What should I do if my hemorrhoidal bleeding persists despite topical corticosteroid therapy?
In a 50-year-old man with total prostate-specific antigen 0.4 ng/mL, free PSA 0.1 ng/mL (free-to-total ratio 25%) and no urinary symptoms or risk factors, what is the appropriate next step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.